Insulin resistance in non-alcoholic steatohepatitis (Q42506581)

1 November 2017

Insulin resistance in non-alcoholic steatohepatitis (English)

1 reference

1 November 2017

0 references

1 reference

1 reference

Cömert B

1

1 reference

1 November 2017

Mas MR

2

1 reference

1 November 2017

Erdem H

3

1 reference

1 November 2017

Dinc A

4

1 reference

1 November 2017

Saglamkaya U

5

1 reference

1 November 2017

Cigerim M

6

1 reference

1 November 2017

Kuzhan O

7

1 reference

1 November 2017

Unal T

8

1 reference

1 November 2017

Kocabalkan F

9

1 reference

1 November 2017

1 May 2001

1 reference

Digestive and Liver Disease

1 November 2017

1 reference

1 November 2017

33

1 reference

1 November 2017

353-358

1 reference

1 November 2017

4

1 reference

Nonalcoholic Steatohepatitis

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Fatty liver hepatitis and cirrhosis in obese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Effect of insulin and plasma amino acid concentration on leucine metabolism in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Glucose intolerance and hyperinsulinemia of cirrhosis are not results of spontaneous or surgical portosystemic shunting.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Immunoassay of insulin with insulin-antibody precipitate

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Radioimmunological determination of human C-peptide in serum

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Glucose tolerance and diabetes in chronic liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

The euglycemic clamp technique in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Insulin action in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Regulation of hepatic fatty acid oxidation and ketone body production

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Steatohepatitis: a tale of two "hits"?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Hepatic iron and nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

Insulin resistance-associated hepatic iron overload.

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2801%2980091-8

7 January 2021

10.1016/S1590-8658(01)80091-8

Identifiers

DOI

1 reference

release_b26yk4lfl5b4vllqt7j7sth72m

1 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/b26yk4lfl5b4vllqt7j7sth72m

24 November 2022

mapped directly with Wikidata item

1 reference